❭ Research by medical division ❭ Surgery and Specialized Medicine ❭ Research Institute of Internal Medicine (RIIM) ❭
Page visits: 1
Scroll to top

Home Surgery and Specialized Medicine Research Institute of Internal Medicine (RIIM)

  • Immune regulation in atherosclerosis and other cardio metabolic diseases [Halvorsen]
  • Genomics and Metagenomics in Inflammatory Disorders [Hov]
  • Inflammatory Biomarkers in Cardiovascular and Metabolic Disease [Ueland]
  • The Experimental liver research group [Melum]
  • Infectious immunology [Trøseid]
  • Haemostasis, Thrombosis and Vascular Biology Research [Stavik]
  • RIIM Collaborators
  • RIIM publications
  • Research profile
  • Organization
  • Economy
  • Annual reports
  • Image gallery
  • Media outlets

Recent publications

Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA (2025)
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70117, PubMed 40852937

Nilsen DWT, Leon De La Fuente R, Gallo P, Naesgaard P, Dib Ashur S, Michelsen AE, Aukrust P, Staines H, Ueland T (2025)
Reply to: Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
Int J Cardiol, 133812 (in press)
DOI 10.1016/j.ijcard.2025.133812, PubMed 40850571

Nilsen DWT, Leon De La Fuente R, Gallo P, Naesgaard P, Dib Ashur S, Michelsen AE, Aukrust P, Staines H, Ueland T (2025)
Reply to: Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients
Int J Cardiol, 133807 (in press)
DOI 10.1016/j.ijcard.2025.133807, PubMed 40840598

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)